Summary & Overview
HCPCS J7632: Cromolyn Sodium Inhalation Solution, Compounded, DME Unit Dose
HCPCS Level II code J7632 represents a compounded inhalation formulation of cromolyn sodium, supplied as a unit dose of 10 milligrams and administered via durable medical equipment (DME) such as a nebulizer. Nationally, this code is relevant for coverage determinations, DME-related administration policies, and pharmacy compounding billing for inhaled therapies used in airway inflammatory conditions. It matters because compounded inhalation products intersect pharmacy, DME, and medical benefit rules, affecting reimbursement pathways and provider documentation requirements.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. The publication summarizes how coverage and billing practices typically apply to compounded inhalation solutions administered through DME and highlights areas where payers often set requirements for medical necessity, supplier enrollment, and documentation.
Readers will learn the clinical and billing context of J7632, expected site-of-service considerations, and typical administrative workflows tied to DME administration of inhalation solutions. The report also outlines common modifiers associated with similar services and identifies where input data is missing. Data not available in the input: associated taxonomies, ICD-10 diagnoses, related codes, and service line specifics. The content provides a concise reference for coding teams, billing staff, and policy analysts handling compounded inhalation drug claims involving DME.
Billing Code Overview
HCPCS Level II code J7632 describes cromolyn sodium, inhalation solution, compounded product, administered through durable medical equipment (DME), unit dose form, per 10 milligrams. This entry represents a compounded inhalation medication formulation of cromolyn sodium intended for aerosol administration via DME devices such as nebulizers.
Service type: Drug administration (inhalation), compounded inhalation solution
Typical site of service: Home or outpatient setting where durable medical equipment (nebulizer) is used
Clinical & Coding Specifications
Clinical Context
A typical patient is a pediatric or adult patient with chronic allergic or exercise-induced asthma for whom cromolyn sodium inhalation solution is prescribed as an alternative nonsteroidal mast cell stabilizer. The compounded J7632 product is prepared in unit-dose vials and administered via a patient-owned or durable medical equipment (DME) nebulizer in an outpatient clinic, home health setting, or skilled nursing facility when a ready-to-use commercial formulation is unavailable or when individualized compounding is required for dosing or preservative-free preparations. The clinical workflow includes a clinician visit to assess indication and inhaled medication history, a written prescription specifying the compounded inhalation solution strength and volume, pharmacy compounding and labeling of unit-dose vials, delivery to the patient or administration by a respiratory therapist, and documentation of medication administration, lot number, and patient response. Typical monitoring includes assessment of respiratory symptoms, peak flow or spirometry when indicated, and instruction on nebulizer use and storage of unit-dose vials.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the compounding or administration requires substantially greater work than usual (rare for standard nebulized inhalation solutions). |